• Home  
  • BIOTech Caucus, Isomorphic, Merck, Erasca: Readout Newsletter
BIOTech Caucus, Isomorphic, Merck, Erasca: Readout Newsletter
- Health

BIOTech Caucus, Isomorphic, Merck, Erasca: Readout Newsletter

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. With Heidi Overton out, who’s gonna lead the FDA? We should endeavor a guess, March Madness-style. STAT Madness, regulatory edition.  Merck enlists Isomorphic for mystery target Merck already has an oncology target it considers

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

With Heidi Overton out, who’s gonna lead the FDA? We should endeavor a guess, March Madness-style. STAT Madness, regulatory edition. 

Merck enlists Isomorphic for mystery target

Merck already has an oncology target it considers strategically important — and a trove of wet lab data from its own work on it. Now, STAT’s Katherine MacPhail writes exclusively, it’s bringing in Isomorphic Labs to see whether the DeepMind spinoff’s AI models can use those data to find promising small molecules faster.

STAT+ Exclusive Story





This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Source: www.statnews.com

About Us

Toolq Media Is a Global News Platform Covering the Latest Developments and Breaking Stories from Around The World, Including World News, Business, Finance, Technology, Health, Politics, Science, Entertainment, Sports, and More.

Toolq

Toolq @2026. All Rights Reserved.